Abbott Laboratories (ABT)Fideuram Asset Management (Ireland) dac added to its stake +147K shares

149K

Shares reported · +147K vs prior quarter

0.25%

Disclosed portfolio weight

$13.4M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
2. Apr 16, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
3. May 7, 2026Insider · Their largest buy since 2019Director purchased ~$174K of ABT shares in the open market
4. May 12, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
5. May 15, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
6. May 27, 2026Government · Federal Register noticeDrugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661
7. May 27, 2026CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
8. Jun 12, 2026Congress · 1 personMembers of Congress: 2 purchases
9. Jun 16, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
10. Jun 17, 2026FDAFDA device clearance: Amplatzer TorqVue Exchange System
11. Jul 2, 2026FDAFDA device clearance: Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter
12. Jul 7, 2026Government · Federal Register proposed ruleMedicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
13. Jul 8, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
14. Jul 14, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
15. Jul 15, 2026FDAFDA device clearance: EnSite™ X EP System
16. Jul 16, 2026Company filing · Form 8-K · ResultsReported its results
17. Jul 17, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000

What came next

1. Jul 30, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
2. Aug 6, 2026Government · Federal Register noticeForeign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas
3. Aug 11, 2026InsiderOfficer sold ~$643K of ABT shares in the open market
4. Aug 25, 2026Insider · 1 personInsiders: 2 sales (~$46.2M)
5. Sep 2, 2026InsiderOfficer sold ~$3K of ABT shares in the open market
6. Sep 17, 2026FDAFDA device clearance: EnSite™ X EP System
7. Sep 23, 2026FDAFDA device clearance: Anti-HCV Next

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 82 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

How this filing works

• SEC Form 13F

Other disclosures at Abbott Laboratories

• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 20, 2026

Everything OQRO holds on this company is on its ABT page.